Jefferies Raises Price Target on Ardea Biosciences (RDEA), Maintains Buy Rating

January 7, 2011 11:50 AM EST Send to a Friend
Jefferies is keeping their Buy rating on Ardea Biosciences (NASDAQ: RDEA) as they feel that RDEA594 will become the standard-of-care ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login